Skip to content
healthcare.dev

Zenpep

NDC 73562-111, pancrelipase lipase, pancrelipase protease, pancrelipase amylase, capsule, delayed release, from Aimmune Therapeutics, Inc..

Product NDC
73562-111
Status
Listed
Labeler
Aimmune Therapeutics, Inc.
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA022210
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73562-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PANCRELIPASE LIPASE15000 [USP'U]/1
  • PANCRELIPASE PROTEASE47000 [USP'U]/1
  • PANCRELIPASE AMYLASE63000 [USP'U]/1
Package NDCNDC-11Package
73562-111-0173562011101100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-111-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f16f2d4-8df6-4bd7-ac10-56994fa257b0
  • NADAC price for package 73562011101

    GET /v1/drugs/nadac/73562011101

Use it

Look up 73562-111 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73562-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73562-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.